Cancer vanishes from every patient’s body in drug trial “miraculously”; Shocked doctors’ say ‘First time in history’. During the trial, the patients have been given Dostarlimab every three weeks for six months. It is to mention that they were all in similar stages of their cancer. The cancer was locally advanced in the rectum but had not spread to other organs.
Unprecedented, the effectiveness of a womb cancer drug undergoing clinical trial has made everyone shocked. The drug, Dostarlimab has seemingly cured every participant in the trial. Those patients suffering from rectal cancer witnessed that their cancer vanished after their experimental treatment. According to reports, total 18 patients in this small clinical trial took Dostarlimab for around six months and after over 12 months the doctors found that their cancer has completely disappeared.
As per experts view, Dostarlimab is a drug with laboratory-produced molecules and it acts as substitute antibodies in the human body. Reportedly, all 18 rectal cancer patients were given same doses of the drug and cancer was completely obliterated in every patient as a result of the treatment. The cancer is thereafter undetectable by physical exam, endoscopy, positron emission tomography or PET scans or MRI scans.
Though the sample size of the trial was quite small, it definitely proves that Dostarlimab can be a potential cure for one of the most deadly common cancers. “The first time this has happened in the history of cancer” said by Dr. Luis A. Diaz J. of New York’s Memorial Sloan Kettering Cancer Center.
It’s worthy to mention, the patients involved in the clinical trial earlier underwent various treatments such as chemotherapy, radiation, and invasive surgery that could result in bowel, urinary, and even sexual dysfunction. Above all, the 18 patients went into the trial expecting to have to go through these as the next step. However, surprisingly, no further treatment was needed.
The experts around the globe has shocked by the findings of this trial and experts have pointed out that complete remission in every single patient.
Several experts have hailed the research as a world-first. Also highlighted that it is more impressive as not all of the patients suffered significant complications from the trial drug. In between, a co-author of the paper, oncologist Dr. Andrea Cercek, described the moment that patients found out they were cancer-free.
“During the trial, no patients had received chemoradiotherapy or undergone surgery, also no cases of progression or recurrence had been reported during follow-up,” researchers wrote in the study published in the New England Journal of Medicine on Sunday.
The scientists have mentioned that the treatment looks promising. However, a larger-scale trial is needed to see if it will work for all patients and if the cancers are truly in remission.
Also read below..